Niki BioSolutions, Inc. (NIKI) stock
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
$1.50−0.20 (-11.76%)
Close on Nov 17, 2026Market cap $12.22MP/E –Yield –
Niki BioSolutions gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2023 it was 2.4%, against 6.2% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 2.4% | −3.7 |
| FY2022 | Dec 31, 2022 | 6.2% | +0.9 |
| FY2021 | Dec 31, 2021 | 5.3% | – |
See a number that looks wrong?